ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer
Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds
Guideline Adherence Improves Early Breast Cancer Survival
Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says
FDA Approves Taxotere For Node+ Breast Cancer
FDA Approves Lilly’s Alimta For Metastatic NSCLC
Reduced Risk of Metastasis When Screening Finds Cancer
Ellence Has Lower Risk Of Heart Damage, Study Finds
Modality Combo Decreases Prostate Cancer Recurrence
Hormonal Therapy Improves Prostate Cancer Survival
Study Suggests Surveillance Colonoscopies Overperformed
Trending Stories
- Brown University reaches agreement with Trump administration to restore funding
- Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel
- House passes Mikaela Naylon Give Kids a Chance Act—next step, the Senate
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Testing for asbestos in talc-based cosmetics seems like a no-brainer—why did FDA withdraw a rule to standardize it?









